None listed
Conditions
Interventions
Medical Device : Thirty dry eye patients are randomly divided into the biodegradable microneedle acupuncture group and the intradermal acupuncture group. For 4 weeks, the interventions are treated 3 t
Sponsors
Naju Dongshin University Korean Medicine Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants should satisfy all following criteria; 1. Male and female patients aged 19-65 at the screening visit. 2. Patients who have typical dry eye symptoms including pruritus, foreign body sensation, pain, dryness, blurry eye, dazzle, eye congestion, and illacrimation, and whose Ocular Surface Disease Index score is more than 13. 3. Less than 10 mm/5 min in Schirmer ? test. 4. Patients who submitted written consent voluntarily.
Exclusion criteria
Exclusion criteria: Patients who satisfy any criterion of the followings cannot participate in this study; 1. Dry eye syndrome caused by eyelid or eyelashes. 2. Irritated eye caused by acute inflammation arose from eyelid, eyeball, or ocualr appendage. 3. Diagnosed as skin diseases including Stevens-Johnson syndrome, pemphigoid, or etc. 4. Diagnosed as vitamin A deficiency. 5. Patients who have damages caused by injury of eyeball or ocular appendage. 6. Patients who had operation to anterior segment of the eye or operation via anterior eye including cataract or LASIK within recent 3 months. 7. Have a difficulty in blink because of facial palsy. 8. Received punctal plug or punctal occlusion. 9. Used anti-inflammatory drops including cyclosporine, corticosteroids, or autoserotherapy directly to the eye within recent 2 weeks. 10. Patients who have active ocular infections including anterior uveitis or anterior blepharitis. 11. Patients who have ocular allergy or who are receiving treatments for allergic eye diseases. 12. Patients who have viral conjunctivitis symptoms or who are receiving treatments for viral conjunctivitis. 13. Patients whose intraocular pressure is more than 25 mmHg in a single eye or both eyes, or who are diagnosed as glaucoma. 14. Receiving systemic corticosteroids or immunosuppressants treatment. 15. Pregnant, lactating women, or women planning pregnancy. 16. Other cases which investigators determined inadequate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ocular Surface Disease Index(OSDI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale for subjective symptoms;Quality of Life;Schirmer ? test;General assessment | — |
Countries
Korea, Republic of
Contacts
Public ContactJi-Hoon Song
Dongshin University
Outcome results
None listed